HC Wainwright & Co. Maintains Buy on IDEAYA Biosciences, Lowers Price Target to $30
HC Wainwright & Co. analyst Edward White maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Buy and lowers the price target from $34 to $30.
Recap: IDEAYA Biosciences Q2 Earnings
Shares of IDEAYA Biosciences (NASDAQ:IDYA) decreased 0.1% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 44.07% year over year to ($0.33), which missed the estimate of ($0.15).
IDEAYA Biosciences Q2 EPS $(0.33) Up From $(0.59) YoY, Sales $8.76M
IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(0.33) per share. This is a 44.07 percent increase over losses of $(0.59) per share from the same period last year. The company reported $8.76 million in
61 Biggest Movers From Yesterday
Gainers
Newegg Commerce, Inc. (NASDAQ: NEGG) shares surged 148.4% to close at $67.57 on Wednesday after jumping around 42% on Tuesday.
Mid-Afternoon Market Update: Dow Rises 70 Points; IDEAYA Biosciences Shares Slide
Toward the end of trading Wednesday, the Dow traded up 0.20% to 34,647.52 while the NASDAQ rose 0.01% to 14,664.04. The S&P also rose, gaining 0.33% to 4,358.01.
Mid-Day Market Update: Crude Oil Down 2.5%; Opiant Pharmaceuticals Shares Jump
Midway through trading Wednesday, the Dow traded down 0.23% to 34,499.42 while the NASDAQ fell 0.30% to 14,619.40. The S&P also fell, dropping 0.11% to 4,338.70.
42 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Newegg Commerce, Inc. (NASDAQ: NEGG) jumped 79% to $48.70 after jumping around 42% on Tuesday.
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 6)
A Peek Into The Markets: US Stock Futures Edge Higher; Fed Minutes In Focus
Pre-open movers
U.S. stock futures traded slightly higher in early pre-market trade ahead of the release of minutes from the FOMC meeting. The Dow Jones dipped more than 200 points on Tuesday, while the S&P 500 recorded its first drop after gaining for seven straight sessions.